Unknown

Dataset Information

0

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.


ABSTRACT:

Objective

RESTORE was a randomized, partially placebo-controlled exploratory study evaluating multiple sclerosis (MS) disease activity during a 24-week interruption of natalizumab.

Methods

Eligible patients were relapse-free through the prior year on natalizumab and had no gadolinium-enhancing lesions on screening brain MRI. Patients were randomized 1:1:2 to continue natalizumab, to switch to placebo, or to receive alternative immunomodulatory therapy (other therapies: IM interferon β-1a [IM IFN-β-1a], glatiramer acetate [GA], or methylprednisolone [MP]). During the 24-week randomized treatment period, patients underwent clinical and MRI assessments every 4 weeks.

Results

Patients (n = 175) were randomized to natalizumab (n = 45), placebo (n = 42), or other therapies (n = 88: IM IFN-β-1a, n = 17; GA, n = 17; MP, n = 54). Of 167 patients evaluable for efficacy, 49 (29%) had MRI disease activity recurrence: 0/45 (0%) natalizumab, 19/41 (46%) placebo, 1/14 (7%) IM IFN-β-1a, 8/15 (53%) GA, and 21/52 (40%) MP. Relapse occurred in 4% of natalizumab patients and in 15%-29% of patients in the other treatment arms. MRI disease activity recurred starting at 12 weeks (n = 3 at week 12) while relapses were reported as early as 4-8 weeks (n = 2 in weeks 4-8) after the last natalizumab dose. Overall, 50/167 patients (30%), all in placebo or other-therapies groups, restarted natalizumab early because of disease activity.

Conclusions

MRI and clinical disease activity recurred in some patients during natalizumab interruption, despite use of other therapies.

Classification of evidence

This study provides Class II evidence that for patients with MS taking natalizumab who are relapse-free for 1 year, stopping natalizumab increases the risk of MS relapse or MRI disease activity as compared with continuing natalizumab.

SUBMITTER: Fox RJ 

PROVIDER: S-EPMC4011468 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4630686 | biostudies-literature
| S-EPMC9910615 | biostudies-literature
| S-EPMC2849739 | biostudies-literature
| S-EPMC5462603 | biostudies-literature
| S-EPMC8482074 | biostudies-literature
| S-EPMC7093683 | biostudies-literature
| S-EPMC4885083 | biostudies-literature
| S-EPMC3257891 | biostudies-literature
| S-EPMC6624093 | biostudies-literature
| S-EPMC6366145 | biostudies-literature